FDA approves Gilead Sciences’ HIV drug cocktail

(Reuters) – Gilead Sciences Inc said on Thursday the U.S. Food and Drug Administration approved its HIV drug cocktail, Genvoya, to treat infection in adults and patients 12 years of age and older. The label also states that Genvoya is not approved to treat patients with chronic hepatitis B virus infection. Genvoya – which is developed from Stribild, an older version of the four drug cocktail – also received positive opinions from European health regulators in September.
Sexual Health News Headlines – Yahoo! News